NON-SEGMENTAL VITILIGO
Clinical trials for NON-SEGMENTAL VITILIGO explained in plain language.
Never miss a new study
Get alerted when new NON-SEGMENTAL VITILIGO trials appear
Sign up with your email to follow new studies for NON-SEGMENTAL VITILIGO, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for vitiligo: drug trial targets facial spots
Disease control TerminatedThis study tested an experimental drug called MK-6194 in 169 adults with non-segmental vitiligo, a condition that causes white patches on the skin. The goal was to see if the drug could reduce the amount of vitiligo on the face compared to a placebo, and to check for side effects…
Matched conditions: NON-SEGMENTAL VITILIGO
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 05:33 UTC
-
New gel shows promise for restoring skin color in vitiligo patients
Disease control TerminatedThis study tested a gel called VYN201 on 205 adults with non-segmental vitiligo, a condition causing white patches on the skin. The goal was to see if the gel could safely improve skin color compared to a placebo gel without active ingredients. Participants applied the gel daily …
Matched conditions: NON-SEGMENTAL VITILIGO
Phase: PHASE2 • Sponsor: Vyne Therapeutics Inc. • Aim: Disease control
Last updated May 18, 2026 12:13 UTC